Skip to content

Intermittent Portal and Graft Purge in Living Donor Liver Transplantation

Intermittent Anti-grade Portal and Graft Purge Ameliorates Post-reperfusion Syndrome in Living Donor Liver Transplantation Recipients. A Prospective, Randomised Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02845154
Acronym
IPLDLT
Enrollment
80
Registered
2016-07-27
Start date
2015-10-31
Completion date
2017-11-30
Last updated
2017-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension, Ischemia Reperfusion Injury

Keywords

Ischemia reperfusion, post-reperfusion syndrome, living donor liver transplantation, patient outcome

Brief summary

Post-reperfusion syndrome and ischemia-reperfusion insult are a common well-known complication in liver transplantation. Several trials investigated variables that my contribute to the generation of these two complications for reducing their incidence and magnitude. The investigators will investigate the effect of acute conditioning of the recipients circulation to the vasoactive mediators in the graft as well as the congested intestine through intermittent purging of graft contents into the patient's systemic circulation in living donor liver transplantation.

Detailed description

Patients are subjected to living donor liver transplantation. In this type of grafts, cold ischemia time is minimal and the graft contents of preservative solution are less than cadaveric grafts. The investigators in the current research use HTC as a preservative solution. These factors justified the possibility of purging the graft and portal blood contents into the patient systemic circulation. The exposure to these fluids in this trial will be in an intermittent manner: the portal vein will be declamped for 5 seconds followed by 30 seconds of portal clamping. This will be repeated twice. The primary outcome objective in this trial will be the incidence of post-reperfusion syndrome. Secondary objectives include the severity of PRS, the incidence and severity of ischemia-reperfusion injury, graft and patient's survival.

Interventions

OTHERbolus purge

complete and uninterrupted purge

OTHERIntermittent purge

intermittent portal purge

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* living donor liver transplantation recipients

Exclusion criteria

* Non

Design outcomes

Primary

MeasureTime frameDescription
Post-reperfusion syndrome5 minutes after portal declampingReduced Mean arterial blood pressure to the predefined value

Secondary

MeasureTime frameDescription
Graft ischemia reperfusion injuryone week post-operativePathological assessment of IR injury based on Suzuli score
Severity of post-reperfusion syndrome5 minutes after portal declamping% decrease in Mean arterial blood pressure
One month patient mortalityone month post-operativeMortality within one post-operative month

Countries

Egypt

Contacts

Primary ContactAmr M Yassen, MD
amryassen@hotmail.com+201001497044
Backup ContactAdel A Hassan, MD
apoadel2004@yahoo.com+201007921234

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026